Carbetocin CAS:37025-55-1

Carbetocin is mainly used to prevent and control postpartum hemorrhage, especially after cesarean section. It reduces the risk of bleeding by enhancing uterine muscle contraction, effectively reducing postpartum blood loss due to childbirth and reducing the need for blood transfusions. Clinical studies have shown that Carbetocin is more durable and stable in controlling postpartum bleeding than traditional oxytocin drugs, because its longer half-life makes its effect more reliable after surgery. In addition, Carbetocin has been studied for other gynecological procedures, such as bleeding prevention after hysterectomy. However, while its effectiveness is widely recognised, Carbetocin needs to be used with caution as individuals may respond differently to the medication and there is a potential risk of adverse reactions and anaphylaxis, which must be evaluated and monitored in detail by a healthcare professional on a case-by-case basis.